104 related articles for article (PubMed ID: 28569194)
21. Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling.
Levin-Iaina N; Dinour D; Romero L; Ron R; Brady RL; Cramer SD; Holtzman EJ
J Urol; 2009 May; 181(5):2146-51. PubMed ID: 19296982
[TBL] [Abstract][Full Text] [Related]
22. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.
Cramer SD; Ferree PM; Lin K; Milliner DS; Holmes RP
Hum Mol Genet; 1999 Oct; 8(11):2063-9. PubMed ID: 10484776
[TBL] [Abstract][Full Text] [Related]
23. Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.
Knight J; Holmes RP; Milliner DS; Monico CG; Cramer SD
Nephrol Dial Transplant; 2006 Aug; 21(8):2292-5. PubMed ID: 16597637
[TBL] [Abstract][Full Text] [Related]
24. Genetic basis of primary hyperoxaluria type II.
Webster KE; Cramer SD
Mol Urol; 2000; 4(4):355-64. PubMed ID: 11156703
[TBL] [Abstract][Full Text] [Related]
25. Missense variants of the alanine: glyoxylate aminotransferase 2 gene correlated with carotid atherosclerosis in the Japanese population.
Yoshino Y; Kohara K; Abe M; Ochi S; Mori Y; Yamashita K; Igase M; Tabara Y; Mori T; Miki T; Ueno S
J Biol Regul Homeost Agents; 2014; 28(4):605-14. PubMed ID: 25620171
[TBL] [Abstract][Full Text] [Related]
26. Primary hyperoxalurias: diagnosis and treatment.
Ben-Shalom E; Frishberg Y
Pediatr Nephrol; 2015 Oct; 30(10):1781-91. PubMed ID: 25519509
[TBL] [Abstract][Full Text] [Related]
27. AGXT2: a promiscuous aminotransferase.
Rodionov RN; Jarzebska N; Weiss N; Lentz SR
Trends Pharmacol Sci; 2014 Nov; 35(11):575-82. PubMed ID: 25294000
[TBL] [Abstract][Full Text] [Related]
28. Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteers.
Kittel A; Müller F; König J; Mieth M; Sticht H; Zolk O; Kralj A; Heinrich MR; Fromm MF; Maas R
PLoS One; 2014; 9(2):e88544. PubMed ID: 24586340
[TBL] [Abstract][Full Text] [Related]
29. A genome-wide association study of the human metabolome in a community-based cohort.
Rhee EP; Ho JE; Chen MH; Shen D; Cheng S; Larson MG; Ghorbani A; Shi X; Helenius IT; O'Donnell CJ; Souza AL; Deik A; Pierce KA; Bullock K; Walford GA; Vasan RS; Florez JC; Clish C; Yeh JR; Wang TJ; Gerszten RE
Cell Metab; 2013 Jul; 18(1):130-43. PubMed ID: 23823483
[TBL] [Abstract][Full Text] [Related]
30. Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
Beck BB; Baasner A; Buescher A; Habbig S; Reintjes N; Kemper MJ; Sikora P; Mache C; Pohl M; Stahl M; Toenshoff B; Pape L; Fehrenbach H; Jacob DE; Grohe B; Wolf MT; Nürnberg G; Yigit G; Salido EC; Hoppe B
Eur J Hum Genet; 2013 Feb; 21(2):162-72. PubMed ID: 22781098
[TBL] [Abstract][Full Text] [Related]
31. 4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
Riedel TJ; Knight J; Murray MS; Milliner DS; Holmes RP; Lowther WT
Biochim Biophys Acta; 2012 Oct; 1822(10):1544-52. PubMed ID: 22771891
[TBL] [Abstract][Full Text] [Related]
32. Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
Belostotsky R; Pitt JJ; Frishberg Y
J Mol Med (Berl); 2012 Dec; 90(12):1497-504. PubMed ID: 22729392
[TBL] [Abstract][Full Text] [Related]
33. The primary hyperoxalurias.
Hoppe B; Beck BB; Milliner DS
Kidney Int; 2009 Jun; 75(12):1264-1271. PubMed ID: 19225556
[TBL] [Abstract][Full Text] [Related]
34. A preliminary account of the properties of recombinant human Glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism.
Mdluli K; Booth MP; Brady RL; Rumsby G
Biochim Biophys Acta; 2005 Dec; 1753(2):209-16. PubMed ID: 16198644
[TBL] [Abstract][Full Text] [Related]
35. Differential chemical diagnosis of primary hyperoxaluria type II. Highly sensitive analysis of optical isomers of glyceric acid by GC/MS as diastereoisomeric derivatives.
Inoue Y; Shinka T; Ohse M; Kuhara T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):2-6. PubMed ID: 16055048
[TBL] [Abstract][Full Text] [Related]
36. New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?
Van Kuilenburg AB; Stroomer AE; Van Lenthe H; Abeling NG; Van Gennip AH
Biochem J; 2004 Apr; 379(Pt 1):119-24. PubMed ID: 14705962
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.
Cregeen DP; Williams EL; Hulton S; Rumsby G
Hum Mutat; 2003 Dec; 22(6):497. PubMed ID: 14635115
[TBL] [Abstract][Full Text] [Related]
38. Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome.
van Woerden CS; Groothoff JW; Wanders RJ; Davin JC; Wijburg FA
Nephrol Dial Transplant; 2003 Feb; 18(2):273-9. PubMed ID: 12543880
[TBL] [Abstract][Full Text] [Related]
39. Primary hyperoxaluria type 2 without L-glycericaciduria: is the disease under-diagnosed?
Rumsby G; Sharma A; Cregeen DP; Solomon LR
Nephrol Dial Transplant; 2001 Aug; 16(8):1697-9. PubMed ID: 11477177
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
